Safety and Efficacy of Ceftazidime/Avibactam in the Treatment of Severe Neonatal Infections

Safety and Efficacy of Ceftazidime/Avibactam in the Treatment of Severe Neonatal Infections

OBJECTIVES: Epidemiological data from China indicates a higher proportion of metallo lactamase produced by Escherichia coli and Klebsiella pneumoniae in pediatric patients compared to adults. Ceftazidime/avibactam (CAZ/AVI), a broad-spectrum antibacterial drug. The efficacy and safety of CAZ/AVI com...

Full description

Saved in:
Bibliographic Details
Main Authors: Mi Zhou, Hongjuan Huang, Lili Huang, Yan Huang, Mengjie Yang
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
newborn, metallo-lactamase, Ceftazidime/Avibactam, Safety, Efficacy
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716524003990
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items